2021-06-24T13:00:41-05:00 2020-09-30 371611326 Aronson LLC 111 ROCKVILLE PIKE SUITE 600 Rockville MD 20850 990 2019-10-01 521317896 HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE INC HENR 2406942000 6720A Rockledge Drive 100 Bethesda MD 20817 Corey Hastings Chief Financial Officer 2021-06-24 true Robert EBY P01682202 3012316200 2019 2022-09-23 18:48:47Z Dr Joseph Caravalho 6720A Rockledge Drive 100 Bethesda MD 20817 508987585 false X www.hjf.org X 1983 MD WITH THE MISSION TO ADVANCE MILITARY MEDICINE, THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC (HJF) IS A GLOBAL NONPROFIT ORGANIZATION PROVIDING INVESTIGATORS AND CLINICIANS SCIENTIFIC, ADMINISTRATIVE AND PROGRAM MANAGEMENT SERVICES. HJF SERVES AS A TRUSTED AND RESPONSIVE LINK BETWEEN THE MILITARY MEDICAL COMMUNITY, FEDERAL AND PRIVATE PARTNERS, AND THE MILLIONS OF AMERICAN SERVICE FAMILIES , VETERANS AND CIVILIANS WHO BENEFIT FROM THE MEDICAL RESEARCH ADVANCES THAT RESULT FROM THIS WORK. 11 11 2919 11 103072 58749 486912404 473027176 2114702 2367498 3659506 1985481 2352713 2335093 495039325 479715248 0 0 216459530 215838990 0 233425 287006818 264111800 503466348 479950790 -8427023 -235542 224661438 268198754 84777261 129578054 139884177 138620700 HJF partners to advance military medicine for our nation's warfighters. As a global nonprofit organization authorized by Congress, HJF provides researchers and clinicians scientific, administrative and program management services. HJF serves as a trusted link between the military medical community, federal and industry partners, and millions of American service families, veterans, and civilians who benefit from its important work. Our warfighters commit to serving the United States of America. HJF helps ensure that military medical innovations reach fruition as quickly and safely as possible, to strengthen these patriots' health and well-being -physically, emotionally, and psychologically-after they serve. Many inventions have been adopted and adapted to benefit civilians over time. As careful stewards of funds from industry partnerships and donors along with grants and contracts from the federal government, HJF carries on the mission of advancing military medicine around the world. false false 472352298 2367498 MEDICAL RESEARCH PROGRAMS: As trusted partners with military medical researchers, important HJF accomplishments include attracting, managing and retaining highly qualified scientific staff to support the priorities of military medicine. Whether it is the senior scientist to lead major initiatives and work collaboratively with US government scientists, or lab techs to perform ongoing research functions, HJF ensures it hires the best and brightest talent to accelerate innovations necessary to advance military medicine. HJF is immensely gratified to report successes in FY20 related to COVID-19 RESEARCH. HJF teams have played a vital role in supporting research partners who pivoted their efforts to studying the novel coronavirus (SARS-CoV-2) and the COVID-19 disease in early 2020. Several research programs went into 24/7 operations with embedded HJF staff working side-by-side with military researchers hyper-focused on finding ways to beat COVID-19. Projects included creating diagnostic tests for COVID-19, developing a vaccine candidate that might apply even to as-yet-unknown coronaviruses, and running clinical trials at several military treatment facilities. One research program quickly initiated two multi-site COVID-19 clinical trials shortly after the initial global pandemic was declared: first, a collaborative, randomized, controlled trial among inpatients with severe COVID-19 disease at DoD military treatment facilities and second, a multidisciplinary observational study of COVID-19 risk factors, clinical course, outcomes, and biomarkers among inpatients and outpatients at DoD military treatment facilities. HJF's scientific and program management staff partner with DoD, academia, government, and industry to run these vital studies and others, with a focus on filling critical gaps in information and improving public health. HJF assisted another infectious disease military research team with the development of a COVID-19 vaccine. The research team selected a lead COVID-19 vaccine candidate to advance manufacturing for human clinical trials. In addition, HJF supported the development of an adjuvant, which is used with the COVID-19 vaccine to increase the immune response. HJF is the coordinator of a consortium that consists of government, nonprofit, academia and industry partners dedicated to improving survival for patients with sepsis in resource limited settings. HJF collaborated with a U.S. military branch to establish the consortium, set research priorities, establish strategic partnerships, and lead overall program implementation. In FY20, this team built upon wearable biosensor technology previously developed with a technology company to track Ebola outbreaks in Africa, applying similar techniques to capture and process continuous physiological data from COVID-19 patients to track disease progression. This program involved military hospitals as well as international sites in Southeast Asia, giving clinicians rapid access to streaming data and analytics. A team of HJF staff is based around the world providing expert operational support to locate and recover the remains of unaccounted-for Department of Defense (DoD) personnel from past conflicts. Their roles reflect their wide range of responsibilities on archeological sites that include archaeologist, historian, program manager, database manager, and more. Their investigation and recovery efforts consist of support for terrestrial and underwater missions, including water and soil testing. In addition to the work performed by the team, HJF collaborates with a wide range of partners, including universities, nonprofit organizations, and others. HJF works with a joint federal agency collaboration focused on creative arts therapies as a highly effective way of improving the health, wellness, and quality of life for military and veteran populations exposed to trauma as well as their families and caregivers. In FY20, 18 creative arts therapists on HJF's team worked in this network, providing art, music, writing and dance/movement therapies, both on-site and through telehealth engagements due to the pandemic. They can be found in a dozen locations across the nation. In FY20, HJF received nearly 200 new awards, grants, agreements, or contracts in addition to the more than 13,000 it has administered since 1983. HJF had more than 1,450 active research protocols in process during FY20 across 19 states and 16 countries, with approximately 2,700 teammates at sites on four continents. 2574521 ENDOWMENT PROGRAMS: In FY20, endowments delivered significant program services to the Uniformed Services University for the Health Sciences (USU), particularly for the School of Medicine and the clinical sciences Department of Surgery and Department of Dermatology. Programs include fellowship grants for graduate students studying military medicine at USU. HJF Fellowship Awards provide travel, education, and training support. 1575131 PARTNERSHIP IN EDUCATION PROGRAMS: Education accounts provide educational, training, and other approved initiatives related to advancing military medicine. Samples of projects funded through educational initiatives include provisioning of textbooks, travel to medical conferences or courses, and support for exams or manuscript publication. One goal of a specific education fund is to improve the clinical experience for those undergoing in-patient cancer treatment. COVID-19 restrictions isolated these immune-compromised patients and severely limited their options for social engagement and entertainment. This initiative provided iPads loaded with apps for each of 14 treatment rooms and is intended to help patients pass the time while at the clinic. 476501950 true true false false false false false false true true false false false true true false true false true true false false false false false false false false true false false false false false false false false false false false false false true true true false false true X 580 0 true 2919 true true true true KE MZ NI PE SF TZ TH false false false true true false false false false false false X 11 11 false false false false false false false true true false false true true true true true true true true false CA CT FL IL MD MA NH NJ NM NY NC OH PA SC VA WA X Daryl Legrande 2406942000 6720A Rockledge Drive Suite 100 Bethesda MD 20817 MR PHILLIP A ODEEN DIRECTOR-CHAIRMAN 1.0 X X 0 0 0 GAIL WILENSKY DIRECTOR 1.0 X 0 0 0 GENERAL JOHN JAY M PAXTON JR DIRECTOR 1.0 X 0 0 0 JOHN DRESSENDORFER DIRECTOR 1.0 X 0 0 0 RICHARD W THOMAS MD DDS EX OFFICIO DIRECTOR 1.0 X 0 0 0 THE HONORABLE BEVERLY BYRON DIRECTOR 1.0 X 0 0 0 THE HONORABLE SALUD CARBJAL EX OFFICIO DIRECTOR 1.0 X 0 0 0 THE HONORABLE US SENATOR JACK REED DIRECTOR 1.0 X 0 0 0 THOMAS W WESTON JR DIRECTOR 1.0 X 0 0 0 US CONGRESSMAN SCOTT DESJARLAIS EX OFFICIO DIRECTOR 1.0 X 0 0 0 US SENATOR JAMES INHOFE DIRECTOR 1.0 X 0 0 0 AIDA LEBBOS SR ASSISTANT GENERAL COUNSEL 40.0 X 193350 0 43179 ALYSSA SHEPARD VP RESEARCH ADMINISTRATION 50.0 X 241644 0 84014 CATHERINE CLARK SR VP, GENERAL COUNSEL SECRETARY 49.0 X 280971 0 49329 COREY HASTINGS CFO 50.3 X 288841 0 49712 CYNTHIA GILMAN SR VP STRATEGIC INITIATIVES 51.6 X 282594 0 61356 ELIZABETH FOLK EVP & COO 49.5 X 407625 0 55116 HILARY LONGO VP COMMUNICATIONS 48.0 X 210801 0 42432 JAN RIZWAN VP&CIO 56.8 X 268745 0 38392 JESSICA BEJARANO VP, COMPLIANCE AND CECO 48.0 X 221686 0 44927 JOSEPH CARAVALHO PRESIDENT/CEO 57.8 X 585787 0 57719 LA SHAUN BERRIEN VP, RESEARCH ADMINISTRATION AND INNOVATION MANAGEMENT 46.0 X 193995 0 39705 MERLIN ROBB VP & CHIEF MEDICAL OFFICER 57.6 X 307318 0 74141 MICHAEL STAMBAUGH CHIEF HR OFFICER 51.5 X 268336 0 36661 RIZWAN JAN VP & CIO 56.8 X 268745 0 38392 WENDY DEAN SR VP, PROGRAM OPERATIONS 51.0 X 238079 0 30630 WILLIAM B KINNER ASSISTANT SECRETARY 44.0 X 230255 0 36327 WILLIAM KINNER DEPUTY GENERAL COUNSEL 44.0 X 230255 0 36327 ADEWUWA ADETOSOYE EXECUTIVE DIRECTOR, TANZANIA 68.2 X 295684 0 32043 EDWARD BLOOM PROGAM MANAGER 40.0 X 297716 0 28170 JEFFREY HOOKE HEAD OF PATHOLOGY 40.0 X 312600 0 61197 MARK SCHER CHIEF TECH TRANSFER OFFICER 53.2 X 297558 0 63693 SANDHYA VASAN DIRECTOR, HJF COMP.OF MHRP &EIDB 53.8 X 264825 0 49126 6187410 0 1052588 494 false true false THE REGENTS OF THE UNIVERSITY OF CALIFORNIA PO BOX 0812 UCA SAN FRANSISCO CA 94143 RESEARCH SERVICES 18195036 MAKERERE UNIVERSITY WALTER REED PO BOX 16524 KAMPALA UG RESEARCH SERVICES 15739852 WINDBER RESEARCH INSTITUTE 600 SOMERSET AVENUE WINDBER PA 15963 RESEARCH SERVICES 4728603 DUKE UNIVERSITY PO BOX 90759 DURHAM NC 27708 RESEARCH SERVICES 4215875 UNIVERSITY OF MICHIGAN BOX 223131 PITTSBURGH PA 15251 RESEARCH SERVICES 2966786 212 472282589 744587 473027176 FEES AND CONTRACTS 541700 2367498 2367498 0 0 0 0 2367498 385205 103072 282133 2335093 2335093 0 0 30872613 29272337 1600276 0 1600276 1600276 0 0 0 0 0 479715248 2367498 103072 4217502 X 3928864 3928864 162262381 125710379 36422251 129751 11251229 8373545 2869083 8601 24496765 18666098 5809995 20672 13899751 10344664 3544461 10626 1277581 1277581 282179 4744 277435 178636131 174111993 4509612 14526 12158837 7360900 4797937 2672763 2418969 252178 1616 356753 271069 43920 41764 2107453 2107453 722054 136949 585105 SUPPLIES 32167739 30614437 1553617 -315 GENERAL SERVICES 21343205 4776714 16564356 2135 EQUIPMENT PURCHASES 6467504 6440883 26621 RENOVATIONS 5134500 5103874 30626 785101 82166732 -81385680 4049 479950790 476501950 3215415 233425 6430562 56486 44686668 55671488 116872539 142190923 0 0 6407016 6334761 24858589 13785714 5818992 11072875 37802522 47224957 6643139 5647264 0 0 0 224661438 268198754 64264089 105417745 4544045 9757143 0 15969127 14403166 84777261 129578054 X 89515074 91528255 50369103 47092445 139884177 138620700 224661438 268198754 X -235542 -1027935 X false true X true true true X 466877838 510026148 498047138 486912404 473027176 2434890704 0 0 466877838 510026148 498047138 486912404 473027176 2434890704 0 2434890704 3042628 3188746 3404433 3431947 2720298 15788052 0 0 0 0 0 0 0 0 0 2450678756 14321836 0.9936 0.9928 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 41919980 14849 831961 2667167 40099623 49939296 14251 2648283 10681850 41919980 97586596 1503326 7778344 56812970 116000 49939296 88729353 763441 12328939 4121137 114000 97586596 85201112 2664712 5469672 4487143 119000 88729353 0.0026 0.2008 0.7966 false false 13480442 5247790 8232652 11378147 8537924 2840223 11072875 Deferred rent 7280785 Other payables 7122381 14403166 X 0 0 0 0 0 0 0 0 0 0 0 0 Schedule D, Part V, Line 4 Intended uses of endowment funds THE FOUNDATION'S ENDOWMENT FUNDS SUPPORT U.S. MILITARY MEDICAL EDUCATION AND RESEARCH AT THE USUHS AND OTHER MILITARY MEDICAL INSTITUTIONS. Schedule D, Part X, Line 2 FIN 48 (ASC 740) footnote UNDER ASC 740-10, ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES, AN ORGANIZATION MUST RECOGNIZE THE TAX BENEFIT ASSOCIATED WITH TAX POSITIONS TAKEN FOR TAX RETURN PURPOSES WHEN IT IS MORE-LIKELY THAN NOT THAT THE POSITION WILL BE SUSTAINED. MANAGEMENT BELIEVES IT HAS NO MATERIAL UNCERTAIN TAX POSITIONS NOR ANY PENALTIES AND INTEREST TO BE ACCRUED FOR THE YEARS ENDED SEPTEMBER 30, 2020 AND 2019, AND, ACCORDINGLY, THERE IS NO LIABILITY FOR UNRECOGNIZED TAX BENEFITS. THE FOUNDATION IS STILL OPEN TO EXAMINATION BY TAXING AUTHORITIES FROM FISCAL YEAR 2017 FORWARD. East Asia and the Pacific 1 9 Program Services SCIENTIFIC AND ADMINISTRATIVE SUPPORT FOR MEDICAL RESEARCH 3996250 Sub-Saharan Africa 5 425 Program Services SCIENTIFIC AND ADMINISTRATIVE SUPPORT FOR MEDICAL RESEARCH 52789407 Middle East and North Africa 0 0 Program Services SCIENTIFIC AND ADMINISTRATIVE SUPPORT FOR MEDICAL RESEARCH 244617 6 434 0 0 6 434 57030274 0 57030274 true false true false false false X X X false false false false false false false false false JAN RIZWAN VP&CIO 250455 0 8000 0 10290 0 19000 0 19392 0 307137 0 0 0 WILLIAM KINNER DEPUTY GENERAL COUNSEL 226179 0 3000 0 1076 0 11341 0 24986 0 266582 0 0 0 AIDA LEBBOS SR ASSISTANT GENERAL COUNSEL 190429 0 2000 0 921 0 25000 0 18179 0 236529 0 0 0 JOSEPH CARAVALHO PRESIDENT/CEO 467611 0 50000 0 68176 0 44000 0 13719 0 643506 0 0 0 ELIZABETH FOLK EVP & COO 357472 0 2000 0 48153 0 25000 0 30116 0 462741 0 0 0 MERLIN ROBB VP & CHIEF MEDICAL OFFICER 292433 0 0 0 14885 0 44000 0 30141 0 381459 0 0 0 CYNTHIA GILMAN SR VP STRATEGIC INITIATIVES 244753 0 3000 0 34841 0 25000 0 36356 0 343950 0 0 0 COREY HASTINGS CFO 264282 0 13500 0 11059 0 18985 0 30727 0 338553 0 0 0 CATHERINE CLARK SR VP, GENERAL COUNSEL SECRETARY 268009 0 2500 0 10462 0 25000 0 24329 0 330300 0 0 0 ALYSSA SHEPARD VP RESEARCH ADMINISTRATION 218880 0 3000 0 19764 0 44000 0 40014 0 325658 0 0 0 RIZWAN JAN VP & CIO 250455 0 8000 0 10290 0 19000 0 19392 0 307137 0 0 0 MICHAEL STAMBAUGH CHIEF HR OFFICER 254526 0 13000 0 810 0 12933 0 23728 0 304997 0 0 0 WENDY DEAN SR VP, PROGRAM OPERATIONS 206091 0 12500 0 19488 0 19231 0 11399 0 268709 0 0 0 JESSICA BEJARANO VP, COMPLIANCE AND CECO 210417 0 3000 0 8269 0 19000 0 25927 0 266613 0 0 0 WILLIAM B KINNER ASSISTANT SECRETARY 226179 0 3000 0 1076 0 11341 0 24986 0 266582 0 0 0 HILARY LONGO VP COMMUNICATIONS 199430 0 2500 0 8871 0 21538 0 20894 0 253233 0 0 0 LA SHAUN BERRIEN VP, RESEARCH ADMINISTRATION AND INNOVATION MANAGEMENT 188398 0 5000 0 597 0 19000 0 20705 0 233700 0 0 0 JEFFREY HOOKE HEAD OF PATHOLOGY 311358 0 0 0 1242 0 15914 0 45283 0 373797 0 0 0 MARK SCHER CHIEF TECH TRANSFER OFFICER 279030 0 1000 0 17528 0 25000 0 38693 0 361251 0 0 0 ADEWUWA ADETOSOYE EXECUTIVE DIRECTOR, TANZANIA 169571 0 10000 0 116113 0 13293 0 18750 0 327727 0 0 0 EDWARD BLOOM PROGAM MANAGER 163773 0 0 0 133943 0 13780 0 14390 0 325886 0 0 0 SANDHYA VASAN DIRECTOR, HJF COMP.OF MHRP &EIDB 253659 0 0 0 11166 0 13016 0 36110 0 313951 0 0 0 Form 990, Part VI, Line 11b Review of form 990 by governing body HJF PROVIDES THE FORM 990 TO THE COUNCIL OF DIRECTORS AS A DRAFT COPY PRIOR TO FILING IT WITH THE IRS. THE COUNCIL PROVIDES ANY COMMENTS THAT ARE TAKEN INTO ACCOUNT FOR THE FINAL RETURN. Form 990, Part VI, Line 12c Conflict of interest policy THE COUNCIL OF DIRECTORS AND ALL EMPLOYEES MUST DISCLOSE ALL ACTUAL AND ANY APPARENT CONFLICTS OF INTEREST. TO COMPLY WITH THIS REQUIREMENT, ALL NEW EMPLOYEES EXECUTE A CONFLICT OF INTEREST DISCLOSURE FORM AS PART OF INITIAL IN-PROCESS. EMPLOYEES ALSO RECERTIFY THEIR CONFLICT OF INTEREST STATUS AT THE CONCLUSION OF THE ONLINE ETHICS TRAINING, WHICH IS COMPLETED BY ALL NEW HIRES. ADDITIONALLY, ALL BOARD MEMBERS AND EMPLOYEES UPDATE THEIR CONFLICT OF INTEREST STATUS ANNUALLY. DIRECTORS HAVE BEEN MADE AWARE OF THEIR OBLIGATION TO REPORT ANY ACTUAL OR PERCEIVED CONFLICTS. THE CONFLICT OF INTEREST UPDATES ARE REVIEWED BY THE ETHICS DEPARTMENT. WHEN APPROPRIATE, THE ETHICS DEPARTMENT WORKS WITH THE EMPLOYEE TO CREATE A MITIGATION PLAN THAT ADDRESSES THE PERCEIVED OR ACTUAL CONFLICT. ANY NEEDED RESTRICTIONS ARE TAILORED TO FIT THE SITUATION AND CAN INCLUDE FOR EXAMPLE, MODIFICATION OF WORK SCHEDULES AND RESTRICTING DECISION MAKING CAPACITY. MITIGATION PLANS ARE REVIEWED BY THE ETHICS OFFICER AND ARE SIGNED BY THE EMPLOYEE AND EMPLOYEE'S SUPERVISOR. Form 990, Part VI, Line 19 Required documents available to the public HJF'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS INCLUDING REPORTS REQUIRED BY THE UNIFORM GUIDANCE ARE AVAILABLE UPON REQUEST. Form 990, Part IX, Line 11g Other Fees Subcontracts - Total Expense: XXX-XX-XXXX, Program Service Expense: XXX-XX-XXXX, Management and General Expenses: 346237, Fundraising Expenses: ; Consulting and other services - Total Expense: 46544290, Program Service Expense: 42366389, Management and General Expenses: 4163375, Fundraising Expenses: 14526; - Total Expense: , Program Service Expense: , Management and General Expenses: , Fundraising Expenses: ; - Total Expense: , Program Service Expense: , Management and General Expenses: , Fundraising Expenses: ; - Total Expense: , Program Service Expense: , Management and General Expenses: , Fundraising Expenses: ; - Total Expense: , Program Service Expense: , Management and General Expenses: , Fundraising Expenses: ; - Total Expense: , Program Service Expense: , Management and General Expenses: , Fundraising Expenses: ; - Total Expense: , Program Service Expense: , Management and General Expenses: , Fundraising Expenses: ; - Total Expense: , Program Service Expense: , Management and General Expenses: , Fundraising Expenses: ; - Total Expense: , Program Service Expense: , Management and General Expenses: , Fundraising Expenses: ; - Total Expense: , Program Service Expense: , Management and General Expenses: , Fundraising Expenses: ; - Total Expense: , Program Service Expense: , Management and General Expenses: , Fundraising Expenses: ; - Total Expense: , Program Service Expense: , Management and General Expenses: , Fundraising Expenses: ; - Total Expense: , Program Service Expense: , Management and General Expenses: , Fundraising Expenses: ; - Total Expense: , Program Service Expense: , Management and General Expenses: , Fundraising Expenses: ; - Total Expense: , Program Service Expense: , Management and General Expenses: , Fundraising Expenses: ; - Total Expense: , Program Service Expense: , Management and General Expenses: , Fundraising Expenses: ; - Total Expense: , Program Service Expense: , Management and General Expenses: , Fundraising Expenses: ; - Total Expense: , Program Service Expense: , Management and General Expenses: , Fundraising Expenses: ; - Total Expense: , Program Service Expense: , Management and General Expenses: , Fundraising Expenses: ; Form 990, Part XI, Line 9 Other changes in net assets or fund balances CUMLATIVE EFFECT OF A CHANGE IN ACCOUNTING PRINCIPLE RELATED TO REVENUE RECOGNITION - 1737302; TO ACCOUNT FOR PRIOR CONSOLIDATION REMOVING SUBSIDIARY ORGANIZATIONS - -2765237; FORM 990, PART VI, LINE 15 HJF UTILIZED A FULL COMPENSATION ANALYSIS PROVIDED BY AN OUTSIDE FIRM TO EVALUATE THE COMPENSATION OF OFFICERS AND KEY POSITIONS, COMPARING POSITIONS TO MARKET AND INDUSTRY COMPENSATION FOR SIMILAR POSITIONS. A FORMAL REVIEW OF SALARIES FOR SIX KEY POSITIONS INCLUDING CEO DETERMINED ALL TO BE REASONABLE. THE COMPENSATION SYSTEM IS A MARKET BASED SYSTEM IN WHICH POSITIONS ARE MARKET PRICED INITIALLY AND THEN MONITORED ANNUALLY BASED ON OVERALL MARKET FACTORS AND SURVEYS FROM INDUSTRY EXPERTS. HJF MEDICAL RESEARCH INTERNATIONAL INC 6720A ROCKLEDGE DR STE 100 BETHESDA MD 20817 522322791 PROGRAM SERVICES MD 501(c)(3) 7 NA true HJF MEDICAL RESEARCH INTERNATIONAL LTD HEALTH RESEARCH NI HJF true false false false false false false false false false false false false false false false true false true true HJF MEDICAL RESEARCH INTERNATIONAL INC P 46382838 FMV HJF MEDICAL RESEARCH INTERNATIONAL INC R 22500000 FMV HJF MEDICAL RESEARCH INTERNATIONAL INC S 38879000 FMV HJF MEDICAL RESEARCH INTERNATIONAL INC LTD P 7255757 FMV HJF MEDICAL RESEARCH INTERNATIONAL INC LTD R 4768408 FMV Schedule R, Part V, Line 2 HJF MEDICAL RESEARCH INTERNATIONAL, INC. AND HJF MEDICAL RESEARCH INTERNATIONAL LTD RECEIVE COST REIMBURSEMENTS FOR ADMINISTERING RESEARCH GRANTS AS SUBRECIPIENTS TO HJF.